Shilpa Singh

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

The University of Texas Southwestern Medical Center(Current)

Harvard University

Dana-Farber Brigham Cancer Center

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Shilpa Singh is an author at The University of Texas Southwestern Medical Center specializing in pharmacy, antifungal agents, and antifungal treatments.

ORCID

Publications per year

2018–2025

Publications

Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer

Leslie Duplaquet, Kevin Kam Fung So, Alexander W. Ying et al. · Cancer Cell · 2024 · 46 citations · Full text

Life Sciences, Cell Biology, Oncology +8

Targeting G1–S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors

Shilpa Singh, Catherine E. Gleason, Min Fang et al. · Nature · 2025 · 18 citations · Full text

Life Sciences, Cell Biology, Medicinal Chemistry +17

Novel and effectual delivery of an antifungal agent for the treatment of persistent vulvovaginal candidiasis

Amita Sarwal, Gurpreet Singh, Shilpa Singh et al. · Journal of Pharmaceutical Investigation · 2018 · 16 citations

Pharmacy, Gynecology, Infectious Diseases +16

1–3 of 3